1. Hidalgo, M., et al.: Patient-derived xenograft models: an emerging plat-form for translational cancer research. Cancer Discov.4, 998–1013 (2014)

   Article  Google Scholar 

2. Tentler, J.J., et al.: Patient-derived tumour xenografts as models for oncology drug development. Nat. Rev. Clin. Oncol.9, 338–350 (2012)

   Article  Google Scholar 

3. Byrne A.T., et al.: Interrogating open issues in cancer precision medicine with patient derived xenografts. In: Nat. Rev. Cancer (2017).https://doi.org/10.1038/nrc.2016.140

   Article  Google Scholar 

4. Bertotti, A., et al.: A molecularly annotated platform of patient-derived xenografts (‘xenopatients’) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer. Cancer Discov.1, 508–523 (2011)

   Article  Google Scholar 

5. Zanella, E.R., et al.: IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies. Sci. Trans. Med. (2015).https://doi.org/10.1126/scitranslmed.3010445

   Article  Google Scholar 

6. Bertotti, A., et al.: The genomic landscape of response to EGFR blockade in colorectal cancer. Nature526, 263–267 (2015)

   Article  Google Scholar 

7. Sartore Bianchi, A., et al.: Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial. Lancet Oncol.17, 738–746 (2016)

   Article  Google Scholar 

8. Illumina: Array-based gene expression analysis. Data Sheet Gene Expr (2011).http://res.illumina.com/documents/products/datasheets/datasheet_gene_exp_analysis.pdf

9. Isella, C., et al.: Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer. Nat. Gen.8, (2017).https://doi.org/10.1038/ncomms15107

10. Barbiero P., Bertotti A., Ciravegna G., Cirrincione G., Pasero E., Piccolo E. : Supervised gene identification in colorectal cancer. In: Quantifying and Processing Biomedical and Behavioral Signals. Springer (2018). ISBN 9783319950945.https://doi.org/10.1007/978-3-319-95095-2_21

    Google Scholar 

11. Barbiero, P., Bertotti, A., Ciravegna, G., Cirrincione, G., Piccolo, E.: DNA microarray classification: evolutionary optimization of neural network hyperparameters. In: Italian Workshop on Neural Networks (WIRN 2018). Vietri Sul Mare, Italy, June 2018

    Google Scholar 

12. Widrow, B., Lehr, M.A.: Artificial neural networks of the perceptron, madaline, and backpropagation family. Neurobionics (1993).https://doi.org/10.1016/B978-0-444-89958-3.50013-9

    Article MATH  Google Scholar 

13. Haykin, S.: Neural Networks: A Comprehensive Foundation. Prentice Hall (1998). ISBN 0132733501

    Google Scholar 

14. Chollet, F., et al.: Keras (2015).https://keras.io

15. Ng, A.Y.: Feature selection, L1 versus L2 regularization, and rotational in-variance. In: International Conference on Machine Learning (2004).https://doi.org/10.1145/1015330.1015435

16. Hastie, T., Tibshirani, R., Friedman, J.: The Elements of Statistical Learning: Data Mining, Inference, and Prediction. Springer Series in Statistics (2009). ISBN 0387848576

    Google Scholar 

17. Kingma D.P., Ba, J.: Adam: a method for stochastic optimization. In: International Conference for Learning Representations (2017).arXiv:1412.6980v9

18. Schmidt, M., Le Roux, N., Bach, F.: Minimizing finite sums with the stochastic average gradient. Math. Prog. (2013).https://doi.org/10.1007/s10107-016-1030-6

    Article MATH  Google Scholar 

19. Defazio, A., Bach, F., Lacoste-Julien, S.: SAGA: a fast incremental gradient method with support for non-strongly convex composite objectives In: Advances in Neural Information Processing Systems (2014).arXiv:1407.0202

Download references